ASAPF
Price
$0.31
Change
+$0.01 (+3.33%)
Updated
Dec 17 closing price
KSRBF
Price
$0.27
Change
-$0.07 (-20.59%)
Updated
Oct 9 closing price
Ad is loading...

ASAPF vs KSRBF

Header iconASAPF vs KSRBF Comparison
Open Charts ASAPF vs KSRBFBanner chart's image
Aurora Spine
Price$0.31
Change+$0.01 (+3.33%)
Volume$5.76K
CapitalizationN/A
Kossan Rubber Industries
Price$0.27
Change-$0.07 (-20.59%)
Volume$200
CapitalizationN/A
ASAPF vs KSRBF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASAPF vs. KSRBF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASAPF is a Hold and KSRBF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ASAPF: $0.31 vs. KSRBF: $0.27)
Brand notoriety: ASAPF and KSRBF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ASAPF: 18% vs. KSRBF: 100%
Market capitalization -- ASAPF: $13.58M vs. KSRBF: $789.51M
ASAPF [@Medical Specialties] is valued at $13.58M. KSRBF’s [@Medical Specialties] market capitalization is $789.51M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASAPF’s FA Score shows that 0 FA rating(s) are green whileKSRBF’s FA Score has 2 green FA rating(s).

  • ASAPF’s FA Score: 0 green, 5 red.
  • KSRBF’s FA Score: 2 green, 3 red.
According to our system of comparison, both ASAPF and KSRBF are a bad buy in the long-term.

Price Growth

ASAPF (@Medical Specialties) experienced а +4.62% price change this week, while KSRBF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.22%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +1.33%.

Industries' Descriptions

@Medical Specialties (-4.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
KSRBF($790M) has a higher market cap than ASAPF($13.6M). ASAPF YTD gains are higher at: 5.845 vs. KSRBF (0.000). KSRBF has higher annual earnings (EBITDA): 144M vs. ASAPF (-675.79K). KSRBF has more cash in the bank: 2.03B vs. ASAPF (362K). ASAPF has less debt than KSRBF: ASAPF (2.93M) vs KSRBF (43.1M). KSRBF has higher revenues than ASAPF: KSRBF (1.85B) vs ASAPF (14.3M).
ASAPFKSRBFASAPF / KSRBF
Capitalization13.6M790M2%
EBITDA-675.79K144M-0%
Gain YTD5.8450.000-
P/E RatioN/A92.59-
Revenue14.3M1.85B1%
Total Cash362K2.03B0%
Total Debt2.93M43.1M7%
FUNDAMENTALS RATINGS
ASAPF: Fundamental Ratings
ASAPF
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
97
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ASAPF and

Correlation & Price change

A.I.dvisor tells us that ASAPF and BVS have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASAPF and BVS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASAPF
1D Price
Change %
ASAPF100%
+2.08%
BVS - ASAPF
10%
Poorly correlated
N/A
INBS - ASAPF
8%
Poorly correlated
-7.07%
LNSR - ASAPF
6%
Poorly correlated
+7.49%
FDMDF - ASAPF
3%
Poorly correlated
N/A
KSRBF - ASAPF
0%
Poorly correlated
N/A
More

KSRBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, KSRBF has been loosely correlated with BRSYF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if KSRBF jumps, then BRSYF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KSRBF
1D Price
Change %
KSRBF100%
N/A
BRSYF - KSRBF
54%
Loosely correlated
N/A
VNRX - KSRBF
26%
Poorly correlated
+2.87%
CALZF - KSRBF
22%
Poorly correlated
N/A
EDTXF - KSRBF
21%
Poorly correlated
-0.21%
ZJYL - KSRBF
20%
Poorly correlated
+9.59%
More